VESAP 4 Notes
VESAP 4 Notes
VESAP 4 Notes
NOTES VESAP 4
Basic science Cerebrovascular
Cerebrovascular Upper extremity
Upper extremity Dialysis access
Aortic and iliac Aortic and iliac
Renal and mesenteric Renal and mesenteric
Lower extremity Lower extremity
Venous and lymphatic Venous and lymphatic
Dialysis access Vascular medicine
Vascular medicine Vascular diagnosis
Vascular imaging Radiation safety
Radiation safety
Critical care PPT FOLDERS
Miscellaneous Basic science
Vascular imaging
Cerebrovascular
Aortic & iliac
*best conduit in children is hypogastric Renal & mesenteric
Upper extremity
Lower extremity
Dialysis access
Venous & lymphatic
Miscellaneous
RUTHERFORD
Ch 90 - Technique: EVAR
…
PFIZER
Hematology
Critical care
Cardiac surgery
Thoracic surgery
Vascular surgery
SABISTON
Congenital heart disease
Acquired heart disease - coronary insufficiency
Acquired heart disease - valvular
Thoracic vasculature
Cerebrovascular disease
Aneurysmal disease
Peripheral arterial occlusive disease
Vascular trauma
Venous disease
Lymphatics
Access and ports
BASIC SCIENCE
ANATOMY
Arterial wall
tunica intima - endothelial cells, connective tissue, elastic tissue
tunica media - ECM with smooth m. cells
tunica adventitia - includes autonomic innervation and vasa vasorum
RESPONSE TO INJURY
Endothelial dysfunction
is the initiating step in atherosclerosis
mechanical or biochemical factors (ie, free radicals from abnormal lipid metabolism, carbon monoxide, tobacco)
balance of factors shifts from to contraction, proliferation, migration of underlying smooth m. cells into intima
also adhesion of platelets, leukocytes, monocytes
Endothelium as mechanosensors
two hemodynamic forces affect endothelial cells
- shear stress frictional force at interface of endothelial surface and circulating blood
- pressure circumferential deformation of blood vessels acting perpendicular to vessel wall
Cell-derived microvesicles
Re-endothelialization
Re-vascularization
BASIC SCIENCE
HEMOSTASIS
PHARMACOLOGY
Anticoagulation
Thrombolysis
Antiplatelet
Hyperlipidemia
Diabetes
Smoking cessation
Anti-hypertensive
Anti-arrhythmic
Pressors, inotropes
PHARMACOLOGY
ANTICOAGULANTS
unfractionated heparin
- binds and enhances ATIII inhibits FIIa and Xa stabilize but does not lyse clot
- use in pts with severe renal insufficiency (GFR < 30)
- monitor PTT
low molecular weight heparin (LMWH)
- mixture of smaller molecules affinity of neutralizing cells/proteins to bind with them eliminates dose-
dependent mechanism of action of unfractionated heparin
» 90% bioavailability after subcutaneous injection
- metabolized by kidneys
- risk for HIT but still possible
warfarin (Coumadin)
- vitamin K antagonist ( F II, VII, IX, X, proteins C, S)
- monitor PT
apixaban (Eliquis) is contraindicated in pts with severe liver disease
argatroban falsely elevates INR, so if bridging to warfarin use INR goal > 4
THROMBOLYTICS
ANTIPLATELETS
clopidogrel (Plavix)
- ADP receptor inhibitor prevents PLT crosslinking
- does not break up existing clots
cilostazol (Pletal)
- inhibits PLT aggregation and causes vasodilation
- sometimes used to tx chronic claudication; no role in acute limb ischemia
- PDEs are contraindicated in pts with heart failure
bupropion
1st line pharmacologic tx for smoking cessation
VASCULAR MEDICINE
VESAP
COMPLICATIONS
Hypofibrinogenemia
complication of lytic therapy
fibrinogen < 100 mg/dl
- immediately stop lytic agent
- if further reverse coagulopathy with cryoprecipitate
Hyperhomocysteinemia
leads to premature arterial disease in children
commonly associated with MTHFR mutation
2-8x risk for MI or stroke, higher in F vs M
normalization of homocysteine doesn't risk of VTE and peripheral arterial thrombosis despite appropriate tx
Cigarette smoking
endothelial damage and altered function
platelet adhesion and permeability of endothelial surfaces to fibrinogen
NO availability and impairs vascular tone
VASCULAR MEDICINE
RISK ASSESSMENT
Brain MRI with diffusion-weighted imaging (DWI) is most Sn and Sp imaging technique for acute infarction
Venous US
^ shows acute thrombosis of GSV and chronic thrombotic disease of femoral vein
VASCULAR DIAGNOSIS
CEREBROVASCULAR
CEREBROVASCULAR
CAROTID
Carotid shunt
used to maintain cerebral perfusion during CEA
indications
- cases in which circle of Willis is not intact, ie, contralateral carotid occlusion
- pts with recent ischemic event will have an area of ischemic penumbra which benefits from increased perfusion
pressure
additional methods to evaluate role of shunting
- transcranial Doppler
- sensory evoke potentials
- cerebral oximetry
hx of contralateral stroke alone is not a general indication for shunt placement
GALA
prospective European multicenter randomized study with 3526 patients
50% underwent CEA with local anesthesia vs. 50% under general anesthesia
no significant difference in incidence of primary outcome of stroke, death, or MI at 30 days
- 4.5% for local vs. 4.8% for general
main benefit for local anesthesia is neurologic monitoring during surgery and selective shunting
Arteritis
Takayasu arteritis
- younger patients, female predominance
- generally affects aorta (ie, middle aortic syndrome) and primary branches
Giant cell arteritis
- older patients, equal M:F
- generally affects more distal arterial segments (ie, axillary artery is common)
management
- endovascular or open intervention is not recommended during active inflammatory phase (ie, fever, myalgia,
rash, ESR)
- primary tx with immunosuppression (ie, steroids) to limit or prevent subsequent occlusive disease
» alternatives if resistant to steroids azathioprine, MTX, MMF, cyclophosphamide; infliximab (anti-TNF alpha)
if resistant to everything
- open surgical reconstruction during quiescent or occlusive phase of disease if symptomatic
» most durable and appropriate revascularization in young patients is bypass graft from ascending aorta (which
is uninvolved in Takayasu)
- angioplasty has recurrent stenosis rate of 50% at mid-term follow up
VERTEBRAL / SUBCLAVIAN
Vertebrobasilar insufficiency
severe carotid disease should be addressed first if present -- may improve vertebrobasilar perfusion via collaterals,
obviating the need for a more complex vertebrobasilar reconstruction
…….
AORTIC & ILIAC
AORTIC & ILIAC
VESAP
THORACIC AORTA
ABDOMINAL AORTA
Endoleak
type 1
- 1a - proximal, 1b - distal
type 2
- associated with hypogastric coil embolization and distal graft extension
Graft infection
Endograft infection
may present with general malaise, weight loss
CT demonstrates air within aneurysm sac
risk factors
- chronic infection in other anatomic sites, groin complications after EVAR, rupture
treatment complete graft excision with in situ or extra-anatomic reconstruction
- in situ reconstruction can use rifampin-soaked Dacron, vein, or cryo-preserved
aortic homograft
» in situ reconstruction is best for low virulence infections (ie, S. aureus or epi)
» extra-anatomic reconstruction better if gram negative, polymicrobial, grossly purulent, necrotic
- risk mortality than explants performed for endoleak
- aortic ligation usually avoided due to risk for stump blowout, major amputation, or reinfection of ax-fem graft
Aortic atherosclerosis
can present with post-prandial abdominal pain (if visceral segment involved) and/or claudication
tx open aortic endarterectomy
- endovascular management has risk for visceral or distal embolization, and dissection-associated occlusion of
visceral vessels
Trauma
infrarenal aortic injury > 50% wall defect + associated colon injury with fecal contamination + hemodynamic instability
- tx synthetic graft repair with omental coverage of graft and fecal diversion
» aortic ligation is fastest option but will result in significant lower extremity hypoperfusion
» delayed, or even expedient extra-anatomic bypass after ligation will contribute to ischemia-reperfusion injury
» saphenous vein patch repair will take too much time and natural hx of this type of repair is not well known
» creation of neoaorta using femoral vein is a more robust conduit but takes too much time and expertise
» primary repair is not an option considering degree of defect
Abdominal exposures
Cattell-Braasch maneuver (R medial visceral rotation) IVC and origin of renal veins
Mattox maneuver (left medial visceral rotation) suprarenal aorta
Blunt injury to common/external iliac artery (ie, MVC with pelvic frx)
high morbidity and mortality
pts with pseudoaneurysm, AVF, or major intimal tears with or without thrombosis endovascular stent
if unstable, open repair is not advised
AORTIC & ILIAC
AORTIC & ILIAC
RUTHERFORD
CH 9 - TECHNIQUE: EVAR
Configurations
bifurcated grafts used in 95% of cases
can be unibody or modular
aorto-uni-iliac (AUI) configuration
- can be used with contralateral iliac occlusion device and fem-fem bypass
- relative indications
» very small (< 15 mm) terminal aorta, which would not accommodate a bifurcated device
» severe unilateral iliac occlusive disease
» secondary tx of migration of a short-body endograft
branched and fenestrated grafts can be used in juxtarenal and/or pararenal aneurysms and thoracic aneurysms where
there is inadequate normal aorta to achieve seal adjacent to a critical side branch
Sizing
factors to consider as per intended use in IFU (instructions for use)
- iliac tortuosity
- vessel diameter (EI)
- angulation of distal neck
- aneurysmal sac orientation
- mural thrombus within aneurysm
- iliofemoral disease (ie, calcification, stenosis)
- iliac length (short iliac contralateral)
- iliac aneurysm (ipsilateral)
neck diameter
- measure at level of lowest renal artery and 15 mm caudal
- grafts should be oversized 10-20% relative to aortic neck, usually about 3-4 mm
» EVAR devices range from 20-36 mm diameters, which txs aortic diameters of 18-32 mm
» TEVAR devices range from 21-45 mm and can tx 16-42 mm
- conical aortic neck
» > 2-3 mm change over the first 15 mm length of aortic length
» when oversizing, split the difference to give > 10% oversizing in large segment and < 30% in smaller segment
» if degree of size mismatch doesn't allow that, EVAR is not advised
length
- count axial cuts from lowest renal artery to aortic bifurcation
» very accurate in absence of tortuosity or neck angulation
» axial measurements underestimate length between bifurcation and hypogastric arteries, esp if tortuous
» length measurements based on centerline calculations overestimate true length
- balleting iliac limbs can facilitate cannulation of contra gate of short-bodied modular grafts
iliac diameters
- oversize 10-20%
Patient selection
character of aortic neck is the major anatomic factor predicting suitability for EVAR
- length, diameter, angulation, shape
- minimum neck length 10-15 mm
- angulation < 45-60°
- maximum diameter 32 mm
AORTIC & ILIAC
- shape
» parallel neck without any eccentric laminated thrombus is ideal
» irregular shaped necks have risk of inadequate seal
› conical or reverse conical (see above)
› localized posterior bulge ("double bubble")
RENAL & MESENTERIC
Look up tx for renal artery aneurysms based on location
Fibromuscular dysplasia
aneurysms associated with FMD are usually only a few mm in size
medial fibroplasia variant is most common
- angiographic appearance of “string of beads”
catheter-based angiography is most accurate imaging technique
- able to visualize smaller branch vessels and identify the changes of aneurysm formation and dissection
- up to 25% of pts will have only branch lesions
management angioplasty alone
- stents are unnecessary and have risk of restenosis
- known complication of angioplasty is dissection which would require a stent
- can treat bilaterally at the same time, no need to stage interventions
Nutcracker syndrome
compression of distal segment of left renal vein between SMA and aorta
symptoms include left flank pain radiating to buttock and hematuria
SMA aneurysms
uncommon, 5.5% of all splanchnic aneurysms
most are proximal
60% have reported infectious etiology (ie, mycotic aneurysm)
tx if > 2 cm even if asymptomatic
- covered stent may not be appropriate depending on length and number of branches
RENAL & MESENTERIC
- open repair associated with 10-15% mortality
Mesenteric collaterals
meandering artery (aka arc of Riolan, artery of Moskowitz) (most prominent) connects SMA and IMA via middle
branch of middle colic artery and ascending branch of left colic artery
pancreaticoduodenal arteries connect celiac axis and SMA
marginal artery of Drummond connects SMA and IMA
hypogastric collateral arises from hemorrhoidal artery
SMA syndrome
characterized by compression of 3rd portion of duodenum by SMA intermittent/partial SBO
can be secondary to loss of mesenteric fat from rapid weight loss or catabolic states
aorto-mesenteric angle < 25° can be associated with duodenal compression (normal 45°)
management
- trial of conservative tx with NJ feeds to restore nutritional status and potentially relieve symptoms
- if fails then duodenojejunostomy can bypass obstruction
- no role for vascular reconstruction
Mesenteric bypass
antegrade bypass from supraceliac aorta is preferred because of long-term patency and straightforward geometry
retrograde bypass
- indicated when antegrade bypass or aortomesenteric endarterectomy are not feasible
RENAL & MESENTERIC
» severe cardiac disease (increases risk of clamping supraceliac aorta)
» inaccessible supraceliac aorta due to previous operations
» severely calcified or aneurysmal supraceliac aorta
- prosthetic graft preferred in absence of infected field due to risk of kinking compared to vein
Exposures
SMA
- in root of mesentery, inferior to pancreas and transverse colon
infrarenal IVC
- Cattell-Braasch maneuver medial rotation of R colon, hepatic flexure, duodenum
UPPER EXTREMITIY
UPPER EXTREMITIY
Subclavian artery stenosis
common but usually asymptomatic
present with > 20 mmHg difference between brachial pressures
sx include exertional arm pain, fatigue, numbness; may have atheroembolic digital ischemia ± tissue loss
tx if symptomatic angioplasty with balloon expandable stent placement if preferred
- usually need to tx regardless of sx if pt has ipsilateral AVF or LIMA-CABG
Raynaud phenomenon
prevalence of 3-5% in general population
triphasic change in skin color - need at least biphasic change for diagnosis
- ischemia (white) cyanosis (blue) reperfusion (red)
associated diagnoses may be rheumatologic (scleroderma, SLE), hematologic (cryoglobulins, paraneoplastic disorder),
neurologic (carpal tunnel), drug-related (ergotamine)
management
- avoid cold, smoking, aggravating medications (ie, caffeine)
- first line drug tx antiplatelet and low-dose DHP CCBs (ie, nifedipine, amlodipine, felodipine)
- alternatives PDE inhibitors (ie, sildenafil), topical nitrates, ARBs, SSRIs
- avoid βB
look up types of Raynaud and waveforms
EXPOSURES
proximal L subclavian
supraclavicular incision
Claudication
ABI < 0.9 suggests arterial occlusive disease
differential diagnosis in young patients
- thromboangiitis obliterans
- adventitial cystic disease - classically associated with loss of distal pluses after knee flexion (Ishikawa sign)
- popliteal artery entrapment
- chronic exertional compartment syndrome
- lower extremity trauma
- infectious embolism
- fibromuscular dysplasia
- vasculitis
- middle aortic syndrome
- persistent sciatic artery
Post-catheterization pseudoaneurysm
risk factors include larger sheaths size, punctures either proximal or distal to CFA, females, anticoagulation
management
LOWER EXTREMITIY
- asymptomatic and < 2 cm conservative management
- symptomatic and/or > 2 cm US-guided manual compression or thrombin injection
- open repair if there is overlying skin changes or unfavorable neck (ie, short, wide neck)
Popliteal entrapment
more common in younger, active patients
Tibial aneurysm
may be secondary to vascular type Elher-Danlos
pt should undergo cardiac evaluation due to risk for coronary disease at younger age
Compartment syndrome
compartments
- anterior …
- lateral superficial peroneal nerve
- superficial posterior soleus muscle
- deep posterior tibial nerve , PT artery, flexor hallicus longus
decision to perform fasciotomies based on clinical criteria (ie, tense compartments with motor or nerve dysfunction)
additional indications
- prolonged ischemia > 6 hours - most commonly accepted indication
- pts who cannot be reliably examined following reperfusion (ie, intubated sedated pt)
- combined arterial and venous injuries necessitating operative repair
- reperfusion associated with arterial reconstruction
- concomitant crush injuries or significant fractures
compartment pressures
- dynamic compartment pressures = mean difference between arterial pressure and intracompartmental pressure
- fasciotomy warranted if difference between intracompartmental pressure and MAP is < 40 mmHg
Pathology
intimal fibroplasia type of FMD intimal collagen deposition and disruption of internal elastic lamina
adventitial cystic disease mucin-containing cystic structures
LOWER EXTREMITIY
- can affect pop, iliac, radial, ulnar arteries and peripheral veins
medial calcific sclerosis dystrophic calcification
- seen in pts with DM and renal failure
Ehler-Danlos syndrome disorganized collagen fibers and rare collagen bundles
Bypass conduits
autogenous vein
prosthetic (ie, polytetrafluoroethylene)
- same intermediate (ie, 2 yr) patency rate as autogenous saphenous vein when used for above knee bypasses
- patency significantly when sewn to below knee targets
cryopreserved vein
- worse patency compared to autogenous vein
Catheter-directed thrombolysis
can be used to treat emboli but may need longer infusion times and use of adjunctive mechanical thrombectomy
absolute contraindications
- recent hemorrhage (ie, GI bleed)
Endovascular stents
covered stents
- allow for immediate restoration of arterial flow in clinical scenarios where thrombolysis may be contraindicated
(ie, recent surgery or hemorrhage)
bare metal stents
- not used for acute and subacute thrombus due to risk for "cheese-grating" with subsequent distal embolization
self-expanding
- more malleable, can be better for longer and more tortuous lesions (ie, SFA)
- use in areas of repetitive motion (ie, distal external iliac)
balloon expanding
- have more radial force and are easier to place precisely (use for any orificial lesions)
Endovascular balloons
plain balloon
drug-coated
- coated with an excipient and paclitaxel
» excipient - aids in transfer of drug from balloon to arterial wall
» paclitaxel
› diffuses through intima to media and adventitia
› has antiproliferative effect on smooth muscle cells primary mechanism for preventing restenosis
- RCTs show superior 1° patency compared to plain balloons when treating SFA lesions
Atherectomy
RCTs show rate of bailout stenting for residual stenosis or dissection compared to PTA with selective stenting
DIALYSIS ACCESS
End stage renal disease
treatment options - AV fistula, PTFE graft, venous catheter, PD catheter, transplant
General considerations
adequate flow rates
minimal complications
long-term patency
acceptable cosmesis
Pre-op considerations
eval site for patency and signs of infection
restrict arm -- no BP or PIVs
Access types
AV fistula
– better 1° and 2° patency than graft
– criticisms of fistula first
- number of non-maturation
- number of remedial procedures (thus cost)
- catheter-dependence time
– maturation (vein arterialization and increase in flow) - median 98 days
AV graft
– large surface area, easy cannulation, preferred by HD techs
– complications
– "maturation" time
– amendable to remediation tx if thrombosis or failure
– unlimited supply
Operative management
General considerations
patency
– autogenous > prosthetic
– larger inflow artery > smaller
– larger outflow vein > smaller
overall cost per patient-yr at risk
– tunneled catheter < AVF < AVG
access as far distally on non-dominant arm if possible
Pre-op evaluation
vein mapping
– prospective RCT showed initial failure rate but no difference in 1° patency at 1 yr
– not needed if pt has adequate visible superficial veins and no signs of central venous stenosis
UE segmental pressures and pulse volume recordings (PVRs) - if any abnormality on pulse exam
arteriography
– allows for identification and possible intervention on arterial inflow stenosis
– in pre-HD pts, risk of contrast may be prohibitive (use segmental pressures and PVRs instead)
AV fistula
requires outflow vein ≥ 3 mm
benefits of regional anesthesia (ie, brachial plexus block)
– vasodilation of artery and vein flow in fistula
- lasts up to 8 weeks post-op
- allows for use of more distal vein
- shown to 1° patency and function at 3 months
– improvement in reported pain control - motor and sensory blockade lasts 6-12 hours
maturation criteria - rule of 6s
– flow rate 600 cc/min
– vein diameter 6 mm
– access depth 6 mm below skin
maturation failure
– inflow artery < 2 mm consistently shown to be associated with failure
– diabetes and female gender associated with failure rates of wrist AVFs
– basilic transposition in obese pts have failure rate
access techniques …
– buttonhole … hematoma, bacteremia/abscess
– rope-ladder …
AV graft
requires outflow vein ≥ 4 mm but does not need to be anatomically accessible
early cannulation grafts (Acuseal, Flixene, Vectra)
- allow for expedited access and time of catheter dependence
- sealing properties of layered graft minimize bleeding at suture line and cannulation holes
- most can be used within 24 hours
- important in pts who are immunosuppressed and have had previous line infections
- may have risk for ischemic steal (Accuseal specifically)
- similar long-term patency as PTFE
DIALYSIS ACCESS
surveillance
- routine duplex every 3-4 months detection of graft stenosis but also invasive interventions with
indeterminate impact on patency
Complications
access dysfunction
– clinical features include absent thrill, discontinuous bruit, edema distal to access, difficult cannulation,
inability to reach target flow, prolonged bleeding, discordance between delivered and prescribed HD dose
(Kt/V)
– other measures of surveillance
- static venous pressures (measured in HD machine)
- access flow measurements
flow measurements performed with US dilution which determine access blood flow after
injecting saline through reversed-line HD circuit
rate < 600 cc/min or > 25% below baseline suggest venous stenosis
early access failure (within 30 days of surgery)
– in absence of technical failure (ie, twisted or stenotic anastomosis), most commonly due to inadequate
venous outflow, which may be secondary to inadequate vein caliber or central venous stenosis
– less common causes included poor arterial inflow, anastomotic stenosis, or hypercoagulable state
early thrombosis
– associated with female gender, forearm AVF, small arterial size, outflow vein 2-3 mm, protamine use
– diabetes and non-compliant arteries have lower frequency of early thrombosis
– short-term antiplatelet use in peri-op period associated with rates of early thrombosis
late thrombosis
– most commonly due to intimal hyperplasia of venous outflow tract
– second most common cause is central venous stenosis
arterial steal hand ischemia
– strategies to risk
- use axillary artery inflow in high-risk pts
- create radiocephalic fistula when feasible
- proximal radial artery instead of brachial for inflow when possible
- limit size of anastomosis if brachial inflow is necessary
- tapered grafts to limit inflow have mixed results
– best test for dx digital plethysmography with and without fistula compression
– management
- evaluate with arteriogram to identify any proximal arterial stenosis
- severe, immediate immediate ligation of AVF
- less severe various techniques to relieve steal symptoms
banding of fistula outflow tract (to resistance in fistula)
proximalization of arterial inflow (PAI)
revision using distal inflow (RUDI)
distal revascularization and interval ligation (DRIL)
- ligation of the arterial outflow tract just distal to arterial anastomosis followed by
bypass from artery proximal to anastomosis to artery distal to area of ligation
- effective in treating ischemic pain and tissue loss but less effective for neurologic
deficits that have already occurred
high output heart failure
– occurs when R-side circulatory volume reduces overall L-side volume HR and stroke volume to
compensate cardiac output ventricular hypertrophy and eventually heart failure
– risk factors include underlying cardiac dz, anemia, upper arm AVF (vs. forearm), males, and upper arm fistula
in same arm a previously functioning forearm fistula
– TTE usually shows LV dilation and pHTN
– management
DIALYSIS ACCESS
- fistula banding - constricts inflow and access volume
banding inflow artery is not recommended
- surgical ligation may be needed if no response to banding
- re-siting AV anastomosis to smaller, distal artery
inotropes (ie, digoxin) are not effective
pseudoaneurysm
– defects in vessel wall due to trauma of repeated punctures (AVG > AVF)
– commonly occurs in pairs due to arterial and venous punctures with each session
– dx is clinical but can be confirmed with duplex ("yin-yang sign" on color-flow is created by turbulent flow)
– intervention indicated if growing or ulcerated
- open tx bypass around involved portion and replace with either transposed vein or prosthetic
- excision of aneurysmal areas is rarely required
- can continue HD by accessing uninvolved part
- can use endovascular covered stent grafts but may incidence of future complications at access site
ischemic monomelic neuropathy
– rare complication that requires prompt dx to avoid permanent neurologic injury
– almost exclusively in diabetics, immediately after creation of a brachiocephalic or antecubital AVF/AVG
– characterized by acute pain and weakness in forearm and hand muscles, wrist drop, often with sensory loss
– underlying cause is sudden diversion of blood supply to nerves of forearm and hand with resulting injury to
nerve fibers
– untx'd pts develop claw-hand deformity with loss of function and severe neuropathic pain
– tx immediate ligation of AVF
seroma (AVG)
– sterile, ultrafiltered serum surrounded by fibrous pseudocapsule
– affects 2-4% of pts with AVG
– caused by failure of synthetic graft to become encapsulated
– may lead to infection, skin necrosis, graft thrombosis, loss of graft puncture area
– tx removal of seroma and replacement of the involved portion of graft
- continued serial aspiration and closed suction drainage are assoc'd with risk for infection
HeRO graft
used in pts with central venous stenosis/occlusion (provided it can be crossed endovascularly)
proximal anastomosis to an artery or existing HD access, device placed in R atrium for direct outflow
- allows for bypass of venous occlusion while maintaining access without bridging with tunneled catheter
lower infection rate compared to tunneled catheter
contraindications
- EF < 20%
- SBP < 100
- brachial a. < 3 mm
- active infection
DIALYSIS ACCESS
Short-term catheters
double lumen non-cuffed catheters that can be placed at bedside
right IJ is preferred with catheter tip at SVC just above RA (best flow rates)
– subclavian has risk for stenosis
– femoral has risk for infection
DIALYSIS ACCESS
RUTHERFORD
General considerations
Dialysis catheters
Complex access
Nonthrombotic complications
VENOUS & LYMPHATIC
Pictures
VENOUS & LYMPHATIC
VESAP
Anatomy
superficial venous system
- greater saphenous vein (GSV) ***
- GSV exits fascia in proximal thigh becomes superficial accessory GSV (aka vena saphena magna accessoria
superficialis)
sural nerve lateral ankle, foot, heel sensation
» adjacent to small saphenous vein (SSV) (see US image below)
Pulmonary embolus
massive PE with hemodynamic instability and R heart failure systemic thrombolysis over catheter directed lysis
Retroperitoneal sarcoma
most common caval tumors
often require en bloc resection of IVC
- < 50% patch angioplasty repair with autogenous vein or bovine pericardium
- > 50% ringed PTFE favored to provide radial force that resists visceral compression, 90% 5 yr patency
Cattell-Braasch maneuver
medial rotation of R colon, hepatic flexure, duodenum exposes infrarenal IVC
Iliofemoral DVT
management
- controversial
» ATTRACT trial showed no significant difference in rate of post-thrombotic syndrome with catheter-directed
thrombolysis vs. anticoagulation alone
» CaVenT trial showed significant rate of post-thrombotic syndrome after catheter-directed thrombolysis
» CHEST guidelines (grade 2C) anticoagulation alone
- patency after open surgical thrombectomy is improved by AV fistula creation
Acute DVT
management
- mechanical prophylaxis serum levels of tPA
- CHEST guidelines anticoagulation alone (over catheter directed thrombolysis) using LMWH over NOACs or vit K
antagonists
VENOUS & LYMPHATIC
- pts with cancer and active malignancy LMWH for first 3 months (ie, dalteparin , enoxaparin)
- catheter directed thrombolysis risk and severity of post-thrombotic syndrome compared to anticoagulation
alone
risk of recurrence highest in pts with active malignancy
- provoked DVT 1% at 1 yr, 3% at 5 yrs
- non-surgical provocation 5% at 1 yr, 15% at 3 yrs
- unprovoked DVT 10% at 1 yr
- active malignancy 15% at 1 yr
Varicose veins
most common manifestation of primary chronic venous insufficiency
Venous ulcers
most important aspect of tx is compression
superficial system should be tx'd in pts with pathologic GSV reflux
CEAP classification
VENOUS & LYMPHATIC
LYMPHEDEMA
Lymphedema
classification based on etiology
- primary (cryptogenic)
» congenital - onset before age 1
› usually sporadic but can be secondary to Milroy disease (autosomal dominant VEGFR-3 mutation),
Noonan syndrome (PTPN11) mutation), Turner syndrome, Klinefelter syndrome, trisomy 21
» praecox - onset age 1-35
» tarda - onset after age 35
- secondary (acquired)
differences from venous insufficiency
- venous edema does not affect toes and usually does not produce a positive Stemmer sign (thicken skin fold at
base of toe)
management of severe unilateral lymphedema
- intensive reduction phase with manual lymphatic drainage (MLD), short-stretch bandaging, exercise, skin care
- maintenance phase with compression wraps, self-MLD, low pressure sequential pneumatic compression
- elastic compression is ineffective if severe
Effective dose
calculation of radiation exposure that reflects the risk of cancer formation
Geometric magnification
positioning patient closer to XR tube and farther from ii
tube current, scatter, skin entrance dose
Bi-planar imaging
total dosage if used for all imaging rather than only when necessary
Deterministic effect
tissue reaction that occurs at a specific threshold dose of exposure
skin injury is the most common
Stochastic effect
occurs with no specific threshold dose
probability increases with increasing dose
ie, cancer, heritable changes in reproductive cells
effective dose is the variable that most accurately predicts stochastic risk
CARDIOVASCULAR
Preload = LV end-diastolic length linearly related to LVEDV and filling pressure NORMAL
Afterload = SVR CO (L/min) 4-8
MAP = CO x SVR CI (L/min) 2.5-4
Cardiac index = CO/BSA SVR 800-1400
Stroke volume = LVEDV - SLVESV determined by LVEDV, contractility, afterload PCWP 11 ± 4
Arterial O2 content (CaO2) = Hb x 1.24 x O2 sat + (PO2 x 0.003) CVP 7 ±2
O2 delivery = CO x CaO2 x 10 PAP 25/10 ± 5
O2 consumption (VO2) = CO x (CaO2 - CvO2) normal delivery-to-consumption ratio is 5:1 SvO2 75 ± 5
Swan-Ganz
should be placed in zone III (lower lung)
relative c/i prior pneumonectomy, LBBB
hemoptysis after flushing Swan PEEP to tamponade the pulmonary artery bleed, mainstem intubate non-affected side, can try Fogarty
balloon down mainstem of affected side, may need thoracotomy and lobectomy
PVR (pulmonary vascular resistance) can only be measured by Swan (not by echo)
distance to wedge
- R SCV 45 cm
- R IJ 50 cm
- L SCV 55 cm
- L IJ 60 cm
PCWP = ***
may be thrown off by pHTN, aortic regurg, mitral stenosis, PEEP, poor LV compliance
A-a gradient
Pacemakers
LVAD
CRITICAL CARE - UNEDITED IMPORT
Pulse
Ox
CRITICAL CARE - UNEDITED IMPORT
ECMO
Receptors
α1 vascular smooth m. constriction, gluconeogenesis, glycogenolysis
α2 venous smooth muscle constriction
β1 myocardial contraction and rate
β2 relaxes bronchial smooth m., relaxes vascular smooth m., insulin, glucagon, renin
DA relax renal and splanchnic smooth m.
SHOCK
***
EMBOLI
***
CO2 embolus
1st - stop insufflation
trendelenburg and L-side down (prevents any more propagation of CO2 into lungs)
ventilate with 100% O2 (CO2 resorbed faster as it comes into equilibrium)
CRITICAL CARE - PHARMACOLOGY
MECHANISM EFFECT
DRUG USE SIDE EFFECT / CONTRAINDICATIONS
α1 α2 β1 β2 DA SVR PVR contract HR
septic or cardiogenic shock
phenylephrine
norepinephrine
dobutamine
isoproterenol
nitroprusside
MISCELLANEOUS
Chlamydia pneumonia bacterium
bug most associated with formation and rupture of atherosclerotic plaques
Trauma exposures
***
Nutrition
respiratory quotient for fatty acids, proteins, carbohydrates, etc.